This inventor holds 1 USPTO granted patent. Top assignee: Universidad De Concepción. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations of Jorge Luis Rivera Parodi in Electrophysiological Testing
Introduction
Jorge Luis Rivera Parodi is an accomplished inventor based in Concepcion, Chile. He has made significant contributions to the field of electrophysiology, particularly in the context of neurodegenerative diseases. His innovative work focuses on developing methods to evaluate neurotoxic capacities and potential pharmacological treatments.
Latest Patents
One of his notable patents is titled "Real time electrophysiological testing of agents of interest for treatment of amyloid-type diseases." This invention corresponds to an in vitro method that employs an electrophysiology technique, specifically the patch-clamp technique in its perforated type. This method allows for the evaluation of the neurotoxic capacity of protein structures associated with neurodegenerative diseases. Additionally, it enables the assessment of potential pharmacological capacities of candidate molecules (drugs) aimed at preventing, treating, or curing these diseases. The invention involves the use of peptides that cause neurodegenerative diseases to form a spontaneous perforated recording that occurs only with peptides in the patch clamp glass pipette.
Career Highlights
Jorge Luis Rivera Parodi has dedicated his career to advancing the understanding of neurodegenerative diseases through innovative research and development. His work has the potential to significantly impact the treatment options available for these conditions.
Collaborations
He has collaborated with notable colleagues, including Luis Gerardo Hernandez Aguayo and Carlos Roberto Martinez Opazo, to further enhance the research and development of his inventions.
Conclusion
Jorge Luis Rivera Parodi's contributions to electrophysiological testing represent a significant advancement in the field of neurodegenerative disease research. His innovative methods and collaborative efforts continue to pave the way for potential breakthroughs in treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile